QDDresearch

Brookdale Senior Living Inc BKD

Health CareHealthcare Providers & ServicesUnited States of America

Last close 10.39 USD on Nov 1, 2026, −3.7% year to date

Quant rating

Quant rating B Rank 156 of 565 in Health Care
  1. Growth A 83 of 565
  2. Valuation A 72 of 565
  3. Quality C 268 of 565
  4. Revisions A 78 of 565
  5. Momentum C 366 of 565

Wall Street consensus Strong Buy (1.33)Average target 19.08 USD +83.7%

Historical valuation

Multiples use consensus estimates for the next twelve months. The dashed line is the 5-year average.

Growth and profitability

Growth and profitability by fiscal year
202520242023202220215Y avg
Revenue (mil)3,1943,1253,0162,8252,758–
Revenue growth2.2%3.6%6.7%2.4%−22.1%−2.0%
EPS (basic, normalized)−1.12−0.89−0.84−1.25−0.54–
EPS growth––––––
Gross margin26.2%25.6%24.8%21.0%18.2%23.2%
Net margin−8.2%−6.5%−6.3%−8.4%−3.6%−6.6%
ROE−313.2%−65.5%−38.3%−37.3%−13.3%−93.5%
Balance sheet, last quarter
Cash & short-term investments (mil)390
Current ratio1.14x
Long-term debt (mil)4,249
Net debt (mil)3,932
Total equity (mil)−29.0
Net debt / equity−135.69x
Net debt / EBITDA8.59x

Estimates and valuation

Consensus estimates and implied multiples
Sales (mil)EBITDA (mil)EPS
Fiscal yearMean est.GrowthEV/SalesMean est.GrowthEV/EBITDAMean est.GrowthP/E
2025 actual 3,194+2.2%2.0x 458+19.4%14.0x −1.12−25.8%−9.3x
2026 2,918−8.6%2.2x 505+10.2%12.7x 0.03+102.7%340.7x
2027 2,995+2.6%2.1x 578+14.5%11.1x 0.17+468.3%59.9x
2028 3,176+6.0%2.0x 650+12.5%9.9x 0.41+136.5%25.3x

Estimate revisions

Change in consensus estimates over 1, 3 and 6 months
SalesEPS
Fiscal yearEstimate (mil)1M3M6MEstimate1M3M6M
20262,918−0.8%−1.8%−2.8%0.03−10.3%+122.9%+114.9%
20272,995−1.1%−2.7%−4.2%0.17+1.0%+20.4%+125.1%
20283,176−1.5%−2.8%−5.5%0.41+0.8%0.0%+24.2%

Earnings surprises

Reported results versus consensus, last 10 fiscal quarters
Quarter endedMar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales reported (mil)783778784781814813813754765719
Sales mean (mil)783779784782817818827766770733
Surprise−0.1%−0.2%0.0%−0.1%−0.4%−0.6%−1.7%−1.6%−0.6%−1.9%
EPS reported−0.13−0.17−0.22−0.37−0.28−0.18−0.20−0.17−0.030.10
EPS mean−0.17−0.15−0.17−0.21−0.11−0.14−0.17−0.17−0.02−0.06
Surprise+25.7%−13.3%−26.9%−76.2%−147.8%−31.9%−17.5%−1.2%−36.4%−280.2%

Peer comparison Healthcare Providers & Services

Peers in the same industry group, by market capitalization
CompanyMarket capNet debt/EBITDANet marginP/BFY1 P/EFY2 P/EFY1 EV/EBITDAFY2 EV/EBITDA
BKD Brookdale Senior Living Inc2.5B8.59x−8.2%−85.64x340.7x59.9x12.7x11.1x
UNH UnitedHealth Group Incorporated365.3B–2.7%3.51x19.8x17.4x13.3x12.1x
CVS CVS Health Corporation115.4B2.50x0.4%1.45x11.2x10.6x8.3x8.0x
HCA HCA Healthcare, Inc.98.8B3.41x9.0%−12.35x15.7x15.1x9.6x9.5x
ELV Elevance Health Inc90.8B–2.8%2.03x14.5x13.9x10.1x10.4x
CI The Cigna Group78.8B2.49x2.2%1.85x9.8x8.9x7.8x7.3x
Mean4.25x1.5%−14.86x68.6x21.0x10.3x9.7x
Median2.96x2.4%1.65x15.1x14.5x9.8x9.9x

Technical analysis

  • 1M−5.9%
  • 3M−32.4%
  • 1Y+17.7%
  • 3Y+164.4%

Financial statements in millions of USD

Income statement, Brookdale Senior Living Inc, fiscal years, most recent first
202520242023202220212020
Total revenue3,1943,1253,0162,8252,7583,540
Cost of revenue2,3572,3262,2692,2312,2572,743
Gross profit838799747594501797
Selling, general & administrative expenses395386381334359431
Research & development––––––
Depreciation/amortization356358343347338359
Interest expense (income), operating––––––
Unusual expense (income)11329.37.0−42.922.994.1
Other operating expenses000000
Operating income−26.625.815.7−44.0−219−86.8
Net interest income (expense)−242−233−219−209−183−206
Gain (loss) on sale of assets00.91.40.6289375
Other non-operating income (expense)3.89.421.712.15.95.6
Net income before taxes−265−197−180−240−10887.3
Provision for taxes−2.04.68.8−1.6−8.25.4
Minority interest0.10.10.1−0.10.10.1
Equity in affiliates––––––
U.S. GAAP adjustment––––––
Net income before extraordinary items−263−202−189−238−99.382.0
Extraordinary items––––––
Net income−263−202−189−238−99.382.0
EBIT, normalized10563.026.6−85.7−19220.7
EBITDA, normalized475431377268153380
Basic EPS, normalized−1.12−0.89−0.84−1.25−0.54–

Disclaimer

The financial data presented in this report is delayed and obtained from sources QDD Research believes to be reliable, including stock exchanges, SEDAR, and EDGAR. However, no representation or warranty is made as to the accuracy, completeness, or timeliness of the information. QDD Research accepts no liability for any errors, omissions, or financial losses arising from the use of this data.

This report is generated using a fully systematic and quantitative approach. All factor scores and the overall quant rating (ranging from D to A+) are derived from algorithmic models and are based solely on objective financial metrics. These scores are intended for informational purposes only and should not be interpreted as investment advice or a recommendation to buy, sell, or hold any securities.

QDD Research is not a registered investment advisor or broker-dealer and does not provide personalized financial advice. The content is not tailored to the specific investment goals, financial situation, or risk profile of any individual investor. We strongly encourage readers to consult with a licensed broker or investment advisor before making any investment decisions based on the information contained in this report.

Live quote provided by TradingView. Report data updated Nov 1, 2026 after market close.